Eastern Pulmonary Conference 2016
The purpose of the Eastern Pulmonary Conference (EPC) is to plan and organize CME meetings on clinical topics in Pulmonary Medicine. EPC blends the interactivity characteristic of small regional conferences together with the cutting edge science characteristic of large national meetings. The educational goal is to share clinically relevant information which improves the diagnostic accuracy and the effectiveness of treatments with practitioners who treat pulmonary diseases.
Target Audience
- Practicing pulmonologists
- Fellows in pulmonary training programs
- Primary care physicians
- Allied Health professionals
Learning Objectives
At the conclusion of this activity, participants should be able to:
· Discuss the basics of stem cell biology, how stem cells are harvested and what emerging clinical uses are currently being studied, including the treatment of idiopathic pulmonary fibrosis
· Outline and apply the current guidelines for the diagnosis and treatment of outpatient community acquired pneumonia and severe pneumonia that requires hospitalization or is acquired in the hospital
· Describe the use of biomarkers and current and future treatment options for asthma and COPD, the approach to clinical exacerbations of COPD, and the causes and clinical consequences of corticosteroid resistance
· Discuss the current molecular approaches to the diagnosis of lung cancers and how novel treatments are applied to these cancers and how the clinician approaches a solitary pulmonary nodule to rule out cancer
· Explain the clinical presentations, treatments and outcomes of two major non-infectious pneumonias: hypersensitivity pneumonitis and chronic organizing pneumonia
· Outline the advances and state of the art practice of endobronchial ultrasound-guided transbronchial needle aspiration
· Discuss the epidemiology, burden of illness and pathophysiology of pulmonary hypertension due to chronic lung disease and the use of newer anticoagulants to treat pulmonary embolic disease
· Explain the recent advances in understanding the pathogenesis of interstitial lung diseases and the advances on treatment in idiopathic pulmonary fibrosis
· Outline the need for immunizations for the pulmonary patient and consequences of poor adherence
· Apply current evidence-based practices to the treatment of critically ill patients with ARDS
· Apply principles regarding tissue hypoxia to the clinical practice including guidelines for air travel for the pulmonary patient
Available Credit
- 14.50 AMA PRA Category 1 Credit™
- 14.50 Attendance